These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6736206

  • 1. Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.
    Beretta-Piccoli C, Weidmann P, Boehringer K, Link L, Bianchetti MG, Morton JJ.
    J Clin Endocrinol Metab; 1984 Aug; 59(2):316-20. PubMed ID: 6736206
    [Abstract] [Full Text] [Related]

  • 2. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y.
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M, Brown RD.
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [Abstract] [Full Text] [Related]

  • 5. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J, Tree M, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JI, Reid JL, Hamilton C.
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Jun; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK.
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [Abstract] [Full Text] [Related]

  • 11. Yohimbine and aldosterone responsiveness to angiotensin II or corticotrophin in normal subjects.
    Lucchini E, Kressebuch H, Beretta-Piccoli C.
    Clin Exp Hypertens A; 1989 Apr; 11(4):649-63. PubMed ID: 2551545
    [Abstract] [Full Text] [Related]

  • 12. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH, Hollenberg NK, Moore TJ, Swartz SL, Dluhy RG.
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [Abstract] [Full Text] [Related]

  • 13. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
    Wisgerhof M, Brown RD.
    J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
    [Abstract] [Full Text] [Related]

  • 14. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
    Pusterla C, Beretta-Piccoli C, Städler P, Weidmann P, Shaw S.
    J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
    [Abstract] [Full Text] [Related]

  • 15. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
    Beretta-Piccoli C, Bianchetti MG, Weidmann P, Boehringer K, Link L, Morton JJ.
    J Cardiovasc Pharmacol; 1982 Mar; 4 Suppl 3():S306-12. PubMed ID: 6184559
    [Abstract] [Full Text] [Related]

  • 16. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
    Marks AD, Marks DB, Kanefsky TM, Adlin VE, Channick BJ.
    J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480
    [Abstract] [Full Text] [Related]

  • 17. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM, Vaughan ED, Peach MJ, Ayers CR.
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [Abstract] [Full Text] [Related]

  • 18. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [Abstract] [Full Text] [Related]

  • 19. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.